debrisoquin has been researched along with proguanil in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Barron, PA; Broughton, JR; Chalcroft, SC; Denton, JR; Pratt, EL; Wanwimolruk, S | 1 |
| Thou, MR; Wanwimolruk, S; Woods, DJ | 1 |
| Bhawan, S; Chalcroft, SC; Coville, PF; Wanwimolruk, S | 1 |
4 other study(ies) available for debrisoquin and proguanil
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Evidence for the polymorphic oxidation of debrisoquine and proguanil in a New Zealand Maori population.
Topics: Adolescent; Adult; Biotransformation; Debrisoquin; Ethnicity; Female; Humans; Male; Middle Aged; New Zealand; Polymorphism, Genetic; Proguanil; White People | 1995 |
Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population.
Topics: Adrenergic Agents; Adult; Antimalarials; Cambodia; Cohort Studies; Debrisoquin; Female; Humans; Male; Middle Aged; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Proguanil | 1995 |
Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations.
Topics: Adolescent; Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Humans; Male; Middle Aged; Mixed Function Oxygenases; Oxidation-Reduction; Polymorphism, Genetic; Polynesia; Proguanil; Reproducibility of Results | 1998 |